Acer Therapeutics Inc logo

Acer Therapeutics Inc

$ 1.35 +0.01 (+0.75%) 10:08 PM EST
P/E:
At Loss
P/B:
0
Market Cap:
$ 21.73M
Enterprise V:
$ 15.68M
Volume:
27.55K
Avg Vol (2M):
114.16K
Also Trade In:
Volume:
27.55K
Market Cap $:
21.73M
PE Ratio:
At Loss
Avg Vol (2-Month):
114.16K
Enterprise Value $:
15.68M
PB Ratio:
0
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Acer Therapeutics Inc operates as a pharmaceutical company. Principally, it is focused on the acquisition, development, and commercialization of therapies for patients with serious rare and ultra-rare diseases with a critical unmet medical need. The company's clinical pipeline includes three categories of severe genetic disorders namely EDSIVO for vEDS, and ACER-001 for urea cycle disorders and maple syrup urine disease.
Name Current Vs Industry Vs History
Cash-To-Debt 1.69
Equity-to-Asset -0.38
Debt-to-Equity -0.98
Debt-to-EBITDA -0.39
Piotroski F-Score 1/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -10.06
Distress
Grey
Safe
Beneish M-Score -3.08
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate 24
3-Year EPS without NRI Growth Rate 24.3
3-Year FCF Growth Rate 81.2
Name Current Vs Industry Vs History
5-Day RSI 36.45
9-Day RSI 39.67
14-Day RSI 42.19
6-1 Month Momentum % -47.39
12-1 Month Momentum % -41.02

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.87
Quick Ratio 0.87
Cash Ratio 0.83
Days Sales Outstanding 7604.17

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -12.4
Name Current Vs Industry Vs History
Operating Margin % -6058.61
Net Margin % -5427.78
ROA % -59.75
ROIC % -72.92
ROC (Joel Greenblatt) % -19335.99
ROCE % -407.71

Financials (Next Earnings Date:2022-11-18 Est.)

ACER's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:ACER

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.36
EPS (TTM) ($) -1.35
Beta 1.61
Volatility % 70.2
14-Day RSI 42.19
14-Day ATR ($) 0.101933
20-Day SMA ($) 1.416475
12-1 Month Momentum % -41.02
52-Week Range ($) 1.1634 - 3.77
Shares Outstanding (Mil) 16.1

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 1
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Acer Therapeutics Inc Filings

Document Form Filing Date
No Filing Data

Acer Therapeutics Inc Analysis

Share your research

Headlines

See More
No news.